Prenetics Global Limited PRE
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +12.76%
- 1 year
- +25.51%
- Open
- 18.75
- Prev close
- 18.98
- Mkt cap
- 346.57M
- Vol
- 101.85K
- Avg vol
- 210.65K
- EPS
- -3.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.30
- High
- 18.84
- Forward P/E
- -10.10
- Beta
- -0.21
- Short ratio
- 3.19
- Inst. own
- 13.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 7, 2024
- 50-d avg
- 4.80
- 200-d avg
- 5.03
- 1y target
- 9.00
YTD chart
Signals (49)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| RSI: Overbought | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| SMA: Bearish | Apr 7, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Mar 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 20, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 19, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| RSI: Overbought | Jan 29, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
Key statistics
- Market cap
- 69.08M
- Enterprise value
- -3.77M
- Trailing P/E
- 0.00
- Forward P/E
- -10.10
- PEG ratio
- 0.00
- Price / sales
- 3.05
- Price / book
- 0.33
- EPS (TTM)
- -3.73
- Beta
- -0.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -219.78%
- Revenue (TTM)
- 22.66M
- Revenue growth
- 4.30%
- Free cash flow
- 0
- Total cash
- 63.89M
- Total debt
- 2.36M
- Return on equity
- -21.67%
- Shares outstanding
- 10.64M
- Short % of float
- 0.37%
- 50-day average
- 4.80
- 200-day average
- 5.03
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Oct 7, 2024
Expected Oct 7, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 27, 2024 | Sep 1, 2024 | 0.00 | -0.84 | — | — |
| Oct 7, 2024 | Jun 1, 2024 | 0.00 | -0.88 | — | — |
| Oct 7, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jun 18, 2024 | Mar 1, 2024 | 0.00 | -0.38 | — | — |
| Jun 18, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -0.52 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 4, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Apr 4, 2024 | Cantor Fitzgerald | main | Overweight | Overweight |
About Prenetics Global Limited
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Hong Kong
- Website
- prenetics.com
News
- Maxim Group Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $41
- CAMTEK PRE-ANNOUNCES RECORD Q3 REVENUES ABOVE GUIDANCE; PROVIDES RECORD Q4 GUIDANCE AND INITIAL REVENUE OUTLOOK FOR 2027
- Lucid Capital Markets Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $54
- SPECTRUM COMMUNITY SOLUTIONS TO BRING PRE-INSTALLED INTERNET AND WIFI TO SILVERWOOD'S NEW COMMUNITY, SILVERWOOD, IN HESPERIA, CALIF.
- Is Prenetics Global Ltd (PRE) a Bargain After 8.1% Drop? GF Value Says Undervalued
- U.S. VEHICLE SALES UNLIKELY TO REGAIN PRE-PANDEMIC LEVELS THIS DECADE, MOBILITY GLOBAL FORECAST SHOWS
- Prenetics Global Limited (NASDAQ:PRE) Receives Consensus Recommendation of “Moderate Buy” from Analysts
- Prenetics Global Q2 2026 Earnings Call: Complete Transcript
- Craig-Hallum Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $40
- B. Riley Securities Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $37
Your note
Sign in to keep a note on PRE — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Prudential PLC | 4.03% | 427,963 | 2.42M | Sep 29, 2024 |
| Aspex Management (HK) Ltd | 3.26% | 346,150 | 1.96M | Sep 29, 2024 |
| Nomura Holdings Inc. | 3.04% | 322,952 | 1.83M | Sep 29, 2024 |
| UBS Group AG | 0.12% | 12,477 | 70.55K | Sep 29, 2024 |
| Morgan Stanley | 0.02% | 2,374 | 13.42K | Sep 29, 2024 |
| Aspire Private Capital, LLC | 0.00% | 114 | 644 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.06% | 6,514 | 36.83K | Oct 30, 2024 |